Benzinga's Top #PreMarket Losers

Vascular Biogenics Ltd.VBLT shares dropped 36.64% to $8.94 in pre-market trading after the company announced the removal of the FDA partial clinical hold on VB-111. VBL Therapeutics announced its plans to discontinue the development of VB-201 in ulcerative colitis and psoriasis following Phase 2 results. Walter Energy, Inc. WLT shares declined 9.17% to $0.99 in pre-market trading after the company reported a wider-than-expected Q4 loss. Cablevision Systems Corporation CVC fell 3.11% to $19.96 in pre-market trading after gaining 1.58% on Friday. Applied Materials, Inc AMAT shares fell 1.70% to $23.71 in pre-market trading after dropping 0.08% on Friday Macy's, Inc.M shares dropped 1.26% to $63.51 in pre-market. Analysts at Barclays initiated coverage on Macy's with a Underweight rating.